Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case‑control study
2022
Fontvieille, Emma | His, Mathilde | Biessy, Carine | Navionis, Anne Sophie | Torres Mejías, Gabriela | Ángeles Llerenas, Angélica | Alvaro Cabrero, Isabel | Sánchez, Gloria Inés | Navarro, Edgar | Rodas Cortes, Yorlany | Porras, Carolina | Rodriguez, Ana Cecilia | Garmendia Miguel, María Luisa | Soto, José Luis | Moyano Schlegel, Leonor Agustina | Porter, Peggy L. | Lin, Ming Gang | Guenthoer, Jamie | Romieu, Isabelle | Rinaldi, Sabina
Background: Breast cancer incidence is increasing rapidly in Latin America, with a higher proportion of cases among young women than in developed countries. Studies have linked inflammation to breast cancer development, but data is limited in premenopausal women, especially in Latin America.
Show more [+] Less [-]Methods: We investigated the associations between serum biomarkers of chronic inflammation (interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), leptin, adiponectin) and risk of premenopausal breast cancer among 453 cases and 453 matched, population-based controls from Chile, Colombia, Costa Rica, and Mexico. Odds ratios (OR) were estimated using conditional logistic regression models. Analyses were stratified by size and hormonal receptor status of the tumors.
Show more [+] Less [-]Results: IL-6 ( ORper standard deviation (SD) = 1.33 (1.11–1.60)) and TNF-α ( ORper SD = 1.32 (1.11–1.58)) were positively associated with breast cancer risk in fully adjusted models. Evidence of heterogeneity by estrogen receptor (ER) status was observed for IL-8 (P-homogeneity = 0.05), with a positive association in ER-negative tumors only. IL-8 (P-homogeneity = 0.06) and TNF-α (P-homogeneity = 0.003) were positively associated with risk in the largest tumors, while for leptin (P-homogeneity = 0.003) a positive association was observed for the smallest tumors only.
Show more [+] Less [-]Conclusions: The results of this study support the implication of chronic inflammation in breast cancer risk in young women in Latin America. Largest studies of prospective design are needed to confirm these findings in premenopausal women.
Show more [+] Less [-]World Health Organization Aparece en contenido como:International Agency for Research on Cancer (IARC) Union for International Cancer Control (UICC) Pan American Health Organization (PAHO) Ibero-American Programme for the Development of Science and Technology (CYTED) Ministerio de Ciencia, Tecnologia e Innovacion (Colombia, MINCIENCIAS) 111584267659
Show more [+] Less [-]Versión publicada - versión final del editor
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by Universidad de Chile